Annual CFI
-$30.54 M
-$62.54 M-195.44%
December 31, 2024
Summary
- As of March 2, 2025, ACAD annual cash flow from investing activities is -$30.54 million, with the most recent change of -$62.54 million (-195.44%) on December 31, 2024.
- During the last 3 years, ACAD annual CFI has risen by +$40.56 million (+57.05%).
- ACAD annual CFI is now -115.86% below its all-time high of $192.51 million, reached on December 31, 2020.
Performance
ACAD Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$122.15 M
+$204.61 M+248.14%
December 31, 2024
Summary
- As of March 2, 2025, ACAD quarterly cash flow from investing activities is $122.15 million, with the most recent change of +$204.61 million (+248.14%) on December 31, 2024.
- Over the past year, ACAD quarterly CFI has increased by +$122.50 million (+35301.73%).
- ACAD quarterly CFI is now -36.55% below its all-time high of $192.52 million, reached on March 31, 2023.
Performance
ACAD Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$30.54 M
+$122.50 M+80.05%
December 31, 2024
Summary
- As of March 2, 2025, ACAD TTM cash flow from investing activities is -$30.54 million, with the most recent change of +$122.50 million (+80.05%) on December 31, 2024.
- Over the past year, ACAD TTM CFI has dropped by -$62.54 million (-195.44%).
- ACAD TTM CFI is now -115.76% below its all-time high of $193.78 million, reached on March 31, 2021.
Performance
ACAD TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ACAD Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -195.4% | +10000.0% | -195.4% |
3 y3 years | +57.0% | +70.7% | +57.0% |
5 y5 years | +81.6% | +158.4% | +81.6% |
ACAD Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -141.7% | +57.0% | -36.5% | +162.9% | -118.8% | +82.5% |
5 y | 5-year | -115.9% | +81.6% | -36.5% | +158.4% | -115.8% | +88.2% |
alltime | all time | -115.9% | +88.3% | -36.5% | +158.4% | -115.8% | +88.9% |
ACADIA Pharmaceuticals Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | -$30.54 M(-195.4%) | $122.15 M(-248.1%) | -$30.54 M(-80.0%) |
Sep 2024 | - | -$82.46 M(+46.7%) | -$153.03 M(+319.6%) |
Jun 2024 | - | -$56.19 M(+300.3%) | -$36.47 M(-79.1%) |
Mar 2024 | - | -$14.04 M(+3945.8%) | -$174.56 M(-645.5%) |
Dec 2023 | $32.00 M(-56.3%) | -$347.00 K(-101.0%) | $32.00 M(+119.2%) |
Sep 2023 | - | $34.11 M(-117.6%) | $14.60 M(-458.5%) |
Jun 2023 | - | -$194.28 M(-200.9%) | -$4.07 M(-103.0%) |
Mar 2023 | - | $192.52 M(-1184.7%) | $134.41 M(+83.5%) |
Dec 2022 | $73.24 M(-203.0%) | -$17.75 M(-214.9%) | $73.24 M(-54.9%) |
Sep 2022 | - | $15.44 M(-127.7%) | $162.54 M(-1862.1%) |
Jun 2022 | - | -$55.80 M(-142.5%) | -$9.22 M(-131.4%) |
Mar 2022 | - | $131.34 M(+83.6%) | $29.37 M(-141.3%) |
Dec 2021 | -$71.10 M(-136.9%) | $71.55 M(-145.8%) | -$71.10 M(-72.6%) |
Sep 2021 | - | -$156.32 M(+808.5%) | -$259.61 M(-622.3%) |
Jun 2021 | - | -$17.21 M(-155.7%) | $49.71 M(-74.3%) |
Mar 2021 | - | $30.88 M(-126.4%) | $193.78 M(+0.7%) |
Dec 2020 | $192.51 M(-216.1%) | -$116.96 M(-176.4%) | $192.51 M(+91.9%) |
Sep 2020 | - | $152.99 M(+20.6%) | $100.32 M(-334.7%) |
Jun 2020 | - | $126.86 M(+328.5%) | -$42.75 M(-73.1%) |
Mar 2020 | - | $29.61 M(-114.2%) | -$158.99 M(-4.1%) |
Dec 2019 | -$165.84 M(+132.0%) | -$209.14 M(-2207.7%) | -$165.84 M(+13.9%) |
Sep 2019 | - | $9.92 M(-6.6%) | -$145.64 M(+17.7%) |
Jun 2019 | - | $10.63 M(-53.3%) | -$123.78 M(-10.5%) |
Mar 2019 | - | $22.76 M(-112.0%) | -$138.35 M(+93.5%) |
Dec 2018 | -$71.49 M(-177.3%) | -$188.95 M(-694.5%) | -$71.49 M(-171.9%) |
Sep 2018 | - | $31.78 M(-906.3%) | $99.37 M(+14.3%) |
Jun 2018 | - | -$3.94 M(-104.4%) | $86.92 M(-32.7%) |
Mar 2018 | - | $89.62 M(-595.3%) | $129.16 M(+39.7%) |
Dec 2017 | $92.47 M(-135.3%) | -$18.09 M(-193.6%) | $92.47 M(-48.5%) |
Sep 2017 | - | $19.33 M(-49.5%) | $179.71 M(+3187.7%) |
Jun 2017 | - | $38.30 M(-27.6%) | $5.47 M(-113.6%) |
Mar 2017 | - | $52.94 M(-23.4%) | -$40.29 M(-84.6%) |
Dec 2016 | -$261.92 M(-277.5%) | $69.14 M(-144.6%) | -$261.92 M(-4.5%) |
Sep 2016 | - | -$154.91 M(+1976.5%) | -$274.34 M(+146.9%) |
Jun 2016 | - | -$7.46 M(-95.6%) | -$111.12 M(+86.5%) |
Mar 2016 | - | -$168.70 M(-397.4%) | -$59.60 M(-140.4%) |
Dec 2015 | $147.57 M(-269.1%) | $56.73 M(+582.8%) | $147.57 M(+12.4%) |
Sep 2015 | - | $8.31 M(-81.1%) | $131.32 M(-18.9%) |
Jun 2015 | - | $44.06 M(+14.5%) | $161.89 M(+221.8%) |
Mar 2015 | - | $38.47 M(-4.9%) | $50.31 M(-157.6%) |
Dec 2014 | -$87.27 M | $40.48 M(+4.1%) | -$87.27 M(-26.2%) |
Sep 2014 | - | $38.87 M(-157.6%) | -$118.21 M(-26.6%) |
Jun 2014 | - | -$67.51 M(-31.9%) | -$161.02 M(-16.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2014 | - | -$99.11 M(-1138.8%) | -$192.13 M(+52.4%) |
Dec 2013 | -$126.10 M(+394.0%) | $9.54 M(-342.0%) | -$126.10 M(-26.1%) |
Sep 2013 | - | -$3.94 M(-96.0%) | -$170.70 M(+0.7%) |
Jun 2013 | - | -$98.62 M(+198.1%) | -$169.50 M(+171.2%) |
Mar 2013 | - | -$33.09 M(-5.6%) | -$62.49 M(+144.8%) |
Dec 2012 | -$25.53 M(-526.9%) | -$35.05 M(+1177.5%) | -$25.53 M(-291.3%) |
Sep 2012 | - | -$2.74 M(-132.7%) | $13.34 M(-35.1%) |
Jun 2012 | - | $8.39 M(+116.5%) | $20.56 M(+10.6%) |
Mar 2012 | - | $3.88 M(+1.6%) | $18.59 M(+210.9%) |
Dec 2011 | $5.98 M(-664.2%) | $3.81 M(-14.8%) | $5.98 M(-206.9%) |
Sep 2011 | - | $4.48 M(-30.3%) | -$5.60 M(-21.5%) |
Jun 2011 | - | $6.42 M(-173.5%) | -$7.13 M(-56.3%) |
Mar 2011 | - | -$8.73 M(+12.5%) | -$16.31 M(+1439.1%) |
Dec 2010 | -$1.06 M(-111.2%) | -$7.76 M(-363.7%) | -$1.06 M(-107.0%) |
Sep 2010 | - | $2.94 M(-206.6%) | $15.23 M(-33.3%) |
Jun 2010 | - | -$2.76 M(-142.4%) | $22.82 M(+378.0%) |
Mar 2010 | - | $6.52 M(-23.6%) | $4.77 M(-49.5%) |
Dec 2009 | $9.44 M(-86.5%) | $8.53 M(-19.0%) | $9.44 M(-24.1%) |
Sep 2009 | - | $10.53 M(-150.6%) | $12.45 M(-38.0%) |
Jun 2009 | - | -$20.80 M(-285.9%) | $20.09 M(-64.3%) |
Mar 2009 | - | $11.19 M(-3.0%) | $56.27 M(-19.3%) |
Dec 2008 | $69.71 M(-266.4%) | $11.53 M(-36.5%) | $69.71 M(+6.7%) |
Sep 2008 | - | $18.17 M(+18.2%) | $65.35 M(+48.0%) |
Jun 2008 | - | $15.38 M(-37.6%) | $44.17 M(-218.6%) |
Mar 2008 | - | $24.64 M(+243.4%) | -$37.24 M(-11.1%) |
Dec 2007 | -$41.90 M(+82.7%) | $7.17 M(-337.7%) | -$41.90 M(-12.9%) |
Sep 2007 | - | -$3.02 M(-95.4%) | -$48.11 M(+5.5%) |
Jun 2007 | - | -$66.03 M(-430.6%) | -$45.62 M(+1178.2%) |
Mar 2007 | - | $19.97 M(+1965.3%) | -$3.57 M(-84.4%) |
Dec 2006 | -$22.94 M(+244.9%) | $967.00 K(-283.1%) | -$22.94 M(+27.8%) |
Sep 2006 | - | -$528.00 K(-97.8%) | -$17.95 M(+349.7%) |
Jun 2006 | - | -$23.98 M(-4070.0%) | -$3.99 M(+27.2%) |
Mar 2006 | - | $604.00 K(-89.8%) | -$3.14 M(-52.8%) |
Dec 2005 | -$6.65 M(-9.9%) | $5.95 M(-55.7%) | -$6.65 M(+122.2%) |
Sep 2005 | - | $13.43 M(-158.1%) | -$2.99 M(-77.6%) |
Jun 2005 | - | -$23.13 M(+695.3%) | -$13.34 M(+2.3%) |
Mar 2005 | - | -$2.91 M(-130.3%) | -$13.04 M(+76.7%) |
Dec 2004 | -$7.38 M(-49.8%) | $9.61 M(+211.0%) | -$7.38 M(-56.6%) |
Sep 2004 | - | $3.09 M(-113.5%) | -$16.99 M(-15.4%) |
Jun 2004 | - | -$22.83 M(-930.0%) | -$20.08 M(-830.0%) |
Mar 2004 | - | $2.75 M | $2.75 M |
Dec 2003 | -$14.69 M(-481.7%) | - | - |
Dec 2002 | $3.85 M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual CFI year-on-year change?
- What is ACADIA Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly CFI year-on-year change?
- What is ACADIA Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM CFI year-on-year change?
What is ACADIA Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ACAD is -$30.54 M
What is the all time high annual CFI for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual cash flow from investing activities is $192.51 M
What is ACADIA Pharmaceuticals annual CFI year-on-year change?
Over the past year, ACAD annual cash flow from investing activities has changed by -$62.54 M (-195.44%)
What is ACADIA Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ACAD is $122.15 M
What is the all time high quarterly CFI for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly cash flow from investing activities is $192.52 M
What is ACADIA Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, ACAD quarterly cash flow from investing activities has changed by +$122.50 M (+35301.73%)
What is ACADIA Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ACAD is -$30.54 M
What is the all time high TTM CFI for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM cash flow from investing activities is $193.78 M
What is ACADIA Pharmaceuticals TTM CFI year-on-year change?
Over the past year, ACAD TTM cash flow from investing activities has changed by -$62.54 M (-195.44%)